Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
983 GBX | -0.71% | -2.48% | +9.96% |
03-26 | Biotech Group Acquisition Withdraws IPO | DJ |
2023 | Biotech Growth's total return underperforms benchmark in tough market | AN |
Sales 2022 | -205M -260M -354M | Sales 2023 | -32.42M -41.17M -56.03M | Capitalization | 303M 385M 524M |
---|---|---|---|---|---|
Net income 2022 | -202M -257M -349M | Net income 2023 | -41M -52.07M -70.87M | EV / Sales 2022 | -1.96 x |
Net Debt 2022 | 31.74M 40.31M 54.87M | Net Debt 2023 | 17.4M 22.1M 30.07M | EV / Sales 2023 | -9.89 x |
P/E ratio 2022 |
-1.84
x | P/E ratio 2023 |
-7.64
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.66% |
1 day | -0.71% | ||
1 week | -2.48% | ||
Current month | +3.04% | ||
1 month | +3.69% | ||
3 months | +2.13% | ||
6 months | +29.17% | ||
Current year | +9.96% |
Members of the board | Title | Age | Since |
---|---|---|---|
Geoffrey Hsu
BRD | Director/Board Member | - | 18-05-15 |
Roger Yates
CHM | Chairman | 67 | 21-11-30 |
Steve Bates
BRD | Director/Board Member | 66 | 15-07-07 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 983 | -0.71% | 17,611 |
24-05-16 | 990 | -1.00% | 13,569 |
24-05-15 | 1,000 | +1.42% | 38,687 |
24-05-14 | 986 | -1.40% | 92,484 |
24-05-13 | 1,000 | -0.79% | 29,969 |
Delayed Quote London S.E., May 17, 2024 at 11:35 am
More quotes1st Jan change | Capi. | |
---|---|---|
+9.96% | 417M | |
+9.83% | 15.12B | |
+8.94% | 6.68B | |
+17.34% | 4.66B | |
+12.77% | 4.52B | |
-6.93% | 4.1B | |
+1.49% | 3.51B | |
+11.30% | 3.21B | |
+0.78% | 2.9B | |
+12.77% | 2.85B |
- Stock Market
- Equities
- BIOG Stock